First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials

Kenneth F. Schulz, Douglas G. Altman, David Moher · Journal of Pharmacology and Pharmacotherapeutics · 2010 · 2.2K citations · Full text

Public Health, Health Policy, Clinical Epidemiology +16

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Jong‐Mu Sun, Lin Shen, Manish A. Shah et al. · The Lancet · 2021 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +14

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

New England Journal of Medicine · 2022 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Florian Lordick, C. Mariette, Karin Haustermans et al. · Annals of Oncology · 2016 · 1.1K citations · Full text

Medicine, Oncology, Surgery +14